// App-Quantinova.ai

85 : The REQUITE Project: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in cancer survivors.

Researchers

Presenter

  • Riccardo Valdagni

Principal Investigators

  • Akke Botma

  • Adam Webb

  • David Azria

  • Tom Burr

  • Jenny Chang-Claude

  • Susan Davidson

  • Rebecca M. Elliot

  • Sara Gutierrez-Enrquez

  • Kerstie Johnson

  • Philippe Lambin

  • Tiziana Rancati

  • Barry Rosenstein

  • Dirk De Ruysscher

  • Chris Talbot

  • Hubert Thierens

  • Ana Vega

  • Frederik Wenz

  • Catharine West

Medical Centers

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • German Cancer Research Centre, Heidelberg, Germany

  • University of Leeds, Leeds, United Kingdom

  • Institut du Cancer de Montpellier, Montpellier, France

  • Source Bioscience, Nottingham, United Kingdom

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

  • University of Manchester, Manchester, United Kingdom

  • Cancer Genomics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain

  • Stichting Maastricht Radiation Oncology, Maastricht, Netherlands

  • Mount Sinai School of Medicine, New York, NY

  • University Hospitals Leuven and KU Leuven, Leuven, Belgium

  • University of Bern, Bern, Germany

  • Fundacion Pblica Galega Medicina Xenomica,, Santiago de Compostela, Spain

  • German Cancer Research Centre, Heidelberg, Germany

  • University of Manchester, Manchester, United Kingdom

Locations

  • Italy

  • Germany

  • United Kingdom

  • France

  • Spain

  • Netherlands

  • United States

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved